TG THERAPEUTICS INC (TGTX)

US88322Q1085 - Common Stock

32.2  +1.25 (+4.04%)

After market: 32.2 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
6.69M
4,360.00%
2.79M
-58.30%
233.662M
8,274.98%
336.74M
44.11%
551.99M
63.92%
761.1M
37.88%
1.125B
47.81%
1.409B
25.24%
1.64B
16.39%
1.782B
8.66%
2.083B
16.89%
EBITDA
YoY % growth
-344.49M
-25.99%
-192.54M
44.11%
20.844M
110.83%
62.347M
199.11%
164.56M
163.94%
179.28M
8.95%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
-344.77M
-26.02%
-192.84M
44.07%
20.633M
110.70%
28.2M
36.67%
175.72M
523.12%
287.71M
63.73%
594.86M
106.76%
818.38M
37.58%
1B
22.19%
1.087B
8.70%
1.392B
28.06%
Operating Margin
-5,153.51%-6,911.83%8.83%8.37%31.83%37.80%52.88%58.08%60.98%61.00%66.83%
EPS
YoY % growth
-2.63
-15.86%
-1.46
44.49%
0.01
100.68%
0.15
1,366.25%
0.98
570.43%
2.01
104.76%
2.64
31.00%
3.99
51.26%
4.83
21.23%
5.14
6.33%
5.76
12.10%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
0.09
188.99%
0.13
283.02%
0.19
377.36%
0.25
1,128.08%
0.33
267.34%
Revenue
Q2Q % growth
100.76M
129.15%
113.04M
78.09%
129.85M
76.75%
145.37M
73.31%
175.95M
74.62%
EBITDA
Q2Q % growth
23.46M
291.14%
N/AN/AN/AN/A
EBIT
Q2Q % growth
16.92M
235.52%
30.008M
423.71%
42.744M
384.85%
55.897M
349.55%
82.484M
387.49%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
0.02
-97.26%
0.03-0.01-33.53%
Q2 2024
Q2Q % growth
0.04
111.76%
-0.050.09185.79%
Q1 2024
Q2Q % growth
-0.07
75.00%
-0.04-0.03-92.18%
Q4 2023
Q2Q % growth
-0.10
74.36%
-0.110.015.99%
Q3 2023
Q2Q % growth
0.73
380.77%
0.120.61518.52%
Q2 2023
Q2Q % growth
-0.34
-13.33%
-0.25-0.09-34.00%
Q1 2023
Q2Q % growth
-0.28
45.10%
-0.370.0925.23%
Q4 2022
Q2Q % growth
-0.39
44.29%
-0.27-0.12-47.06%
Q3 2022
Q2Q % growth
-0.26
60.00%
-0.350.0925.34%
Q2 2022
Q2Q % growth
-0.30
49.15%
-0.520.2242.33%
Q1 2022
Q2Q % growth
-0.51
26.09%
-0.610.1015.87%
Q4 2021
Q2Q % growth
-0.70
1.41%
-0.65-0.05-8.44%
Q3 2021
Q2Q % growth
-0.65
-6.56%
-0.57-0.08-13.22%
Q2 2021
Q2Q % growth
-0.59
-25.53%
-0.51-0.08-15.30%
Q1 2021
Q2Q % growth
-0.69
-43.75%
-0.50-0.19-38.06%
Q4 2020
Q2Q % growth
-0.71
-61.36%
-0.59-0.12-19.67%
Q3 2020
Q2Q % growth
-0.61
11.59%
-0.42-0.19-44.69%
Q2 2020
Q2Q % growth
-0.47
-11.90%
-0.34-0.13-36.33%
Q1 2020
Q2Q % growth
-0.48
-11.63%
-0.37-0.11-31.45%
Q4 2019
Q2Q % growth
-0.44
36.23%
-0.470.035.81%
Q3 2019
Q2Q % growth
-0.69
-60.47%
-0.34-0.35-100.44%
Q2 2019
Q2Q % growth
-0.42
28.81%
-0.41-0.01-1.25%
Q1 2019
Q2Q % growth
-0.43
27.12%
-0.440.013.09%
Q4 2018
Q2Q % growth
-0.69 -0.45-0.24-52.36%
Q3 2018
Q2Q % growth
-0.43 -0.550.1221.93%
Q2 2018
Q2Q % growth
-0.59 -0.54-0.05-10.18%
Q1 2018
Q2Q % growth
-0.59 -0.45-0.14-31.41%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
83.879M
-49.41%
83.34M539K0.65%
Q2 2024
Q2Q % growth
73.466M
357.05%
67.21M6.256M9.31%
Q1 2024
Q2Q % growth
63.474M
713.46%
55.7M7.774M13.96%
Q4 2023
Q2Q % growth
43.971M
43,871.00%
40.865M3.106M7.60%
Q3 2023
Q2Q % growth
165.815M
165,715.00%
47.492M118.323M249.14%
Q2 2023
Q2Q % growth
16.074M
2,579.00%
17.802M-1.728M-9.71%
Q1 2023
Q2Q % growth
7.803M
290.15%
3.447M4.356M126.37%
Q4 2022
Q2Q % growth
100K
-95.65%
1.864M-1.764M-94.64%
Q3 2022
Q2Q % growth
100K
-95.00%
1.726M-1.626M-94.21%
Q2 2022
Q2Q % growth
600K
-60.00%
202.643K397.357K196.09%
Q1 2022
Q2Q % growth
2M
150.00%
2.117M-117K-5.53%
Q4 2021
Q2Q % growth
2.3M 2.281M19K0.83%
Q3 2021
Q2Q % growth
2M 3.027M-1.027M-33.93%
Q2 2021
Q2Q % growth
1.5M 3.559M-2.059M-57.85%
Q1 2021
Q2Q % growth
800K 659.603K140.397K21.29%
Q4 2020
Q2Q % growth
19.38K-19.38K-100.00%
Q3 2020
Q2Q % growth
19.38K-19.38K-100.00%
Q2 2020
Q2Q % growth
29.07K-29.07K-100.00%
Q1 2020
Q2Q % growth
23.256K-23.256K-100.00%
Q4 2019
Q2Q % growth
23.256K-23.256K-100.00%
Q3 2019
Q2Q % growth
27.285K-27.285K-100.00%
Q2 2019
Q2Q % growth
19.38K-19.38K-100.00%
Q1 2019
Q2Q % growth
23.256K-23.256K-100.00%
Q4 2018
Q2Q % growth
31.416K-31.416K-100.00%
Q3 2018
Q2Q % growth
31.416K-31.416K-100.00%
Q2 2018
Q2Q % growth
31.416K-31.416K-100.00%
Q1 2018
Q2Q % growth
31.008K-31.008K-100.00%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-2.79% 1521.01% -2.73% -2.54%
Revenue0% 27.49% 0.26% 0.54%